Eritrea | World Reference Laboratory for Foot-and-Mouth Disease

Eritrea

Country InformationSamples Tested Country Information Official name:State of EritreaWRLFMD code:ERIFMD first recorded: FMD eradicated: Subsequent outbreaks: Serotypes (last rpt): Current status:EndemicUseful websites: FMDV SerotypeYears (not comprehensive)Untyped2005-2009, 2015, 2017-2019O1996, 2004, 2011, 2017A1997-1998, 2006-2009, 2018C-Asia 1-SAT 1-SAT 22019SAT 3-Notesprior to 1993 Eritrea was part of Ethiopia Samples Tested WRLFMD batch no.Date ReceivedVirus samplesTypeTopotypeLineageSublineageWRLFMD ReportsWRLFMD/2004/0003215/12/2004ERI/1/2004OEA-3--DetectionGenotyping(O)ERI/2/2004OEA-3--ERI/3/2004OEA-3--ERI/21/2004OEA-3--ERI/22/2004OEA-3--ERI/4/2004NVD ERI/5/2004NVD ERI/6/2004NVD ERI/7/2004NVD ERI/8/2004NVD ERI/9/2004NVD ERI/10/2004NVD ERI/11/2004NVD ERI/12/2004NVD ERI/13/2004NVD ERI/14/2004NVD ERI/15/2004NVD ERI/16/2004NVD ERI/17/2004NVD ERI/18/2004NVD ERI/19/2004NVD ERI/20/2004NVD ERI/23/2004NVD ERI/24/2004NVD ERI/25/2004NVD ERI/26/2004NVD ERI/27/2004NVD ERI/28/2004NVD ERI/29/2004NVD ERI/30/2004NVD ERI/31/2004NVD WRLFMD/2010/0000220/01/2010ERI/1/2006AAFRICAG-IV-DetectionGenotyping(A)VaccineERI/5/2006AAFRICAG-IV-ERI/4/2007AAFRICAG-IV-ERI/1/2008AAFRICAG-IV-ERI/5/2008AAFRICAG-IV-ERI/16/2009AAFRICAG-IV-ERI/40/2009AAFRICAG-IV-ERI/1/2005FMDV GDnd‑‑ERI/2/2006FMDV GDnd‑‑ERI/3/2006FMDV GDnd‑‑ERI/4/2006FMDV GDnd‑‑ERI/6/2006FMDV GDnd‑‑ERI/2/2007FMDV GDnd‑‑ERI/3/2007FMDV GDnd‑‑ERI/5/2007FMDV GDnd‑‑ERI/7/2007FMDV GDnd‑‑ERI/8/2007FMDV GDnd‑‑ERI/2/2008FMDV GDnd‑‑ERI/4/2008FMDV GDnd‑‑ERI/1/2009FMDV GDnd‑‑ERI/2/2009FMDV GDnd‑‑ERI/3/2009FMDV GDnd‑‑ERI/4/2009FMDV GDnd‑‑ERI/5/2009FMDV GDnd‑‑ERI/6/2009FMDV GDnd‑‑ERI/7/2009FMDV GDnd‑‑ERI/8/2009FMDV GDnd‑‑ERI/17/2009FMDV GDnd‑‑ERI/29/2009FMDV GDnd‑‑ERI/30/2009FMDV GDnd‑‑ERI/31/2009FMDV GDnd‑‑ERI/32/2009FMDV GDnd‑‑ERI/33/2009FMDV GDnd‑‑ERI/34/2009FMDV GDnd‑‑ERI/66/2009FMDV GDnd‑‑ERI/67/2009FMDV GDnd‑‑ERI/1/2007NVD ERI/6/2007NVD ERI/3/2008NVD ERI/9/2009NVD ERI/10/2009NVD ERI/11/2009NVD ERI/12/2009NVD ERI/13/2009NVD ERI/14/2009NVD ERI/15/2009NVD ERI/18/2009NVD ERI/19/2009NVD ERI/20/2009NVD ERI/21/2009NVD ERI/22/2009NVD ERI/23/2009NVD ERI/24/2009NVD ERI/25/2009NVD ERI/26/2009NVD ERI/27/2009NVD ERI/28/2009NVD ERI/35/2009NVD ERI/36/2009NVD ERI/37/2009NVD ERI/38/2009NVD ERI/39/2009NVD ERI/41/2009NVD ERI/42/2009NVD ERI/43/2009NVD ERI/44/2009NVD ERI/45/2009NVD ERI/46/2009NVD ERI/47/2009NVD ERI/48/2009NVD ERI/49/2009NVD ERI/50/2009NVD ERI/51/2009NVD ERI/52/2009NVD ERI/53/2009NVD ERI/54/2009NVD ERI/55/2009NVD ERI/56/2009NVD ERI/57/2009NVD ERI/58/2009NVD ERI/59/2009NVD ERI/60/2009NVD ERI/61/2009NVD ERI/62/2009NVD ERI/63/2009NVD ERI/64/2009NVD ERI/65/2009NVD ERI/68/2009NVD ERI/69/2009NVD WRLFMD/2012/0002901/08/2012ERI/1/2011OEA-3unnamed-DetectionGenotyping (O)ERI/2/2011OEA-3unnamed-ERI/3/2011OEA-3unnamed-ERI/4/2011OEA-3unnamed-ERI/8/2011OEA-3unnamed-ERI/9/2011*Ondnd-ERI/10/2011OEA-3unnamed-ERI/11/2011OEA-3unnamed-ERI/12/2011OEA-3unnamed-ERI/13/2011OEA-3unnamed-ERI/14/2011OEA-3unnamed-ERI/15/2011OEA-3unnamed-ERI/16/2011OEA-3unnamed-ERI/17/2011OEA-3unnamed-ERI/18/2011OEA-3unnamed-ERI/7/2011FMDV GDnd‑‑ERI/5/2011NVD ERI/6/2011NVD WRLFMD/2019/0003118/12/2019ERI/1/2017OEA‑3‑‑DetectionGenotyping(O)Genotyping(A)Genotyping(SAT 2)VaccineERI/2/2017OEA‑3‑‑ERI/3/2017OEA‑3‑‑ERI/4/2017OEA‑3‑‑ERI/7/2017OEA‑3‑‑ERI/8/2017OEA‑3‑‑ERI/7/2018AAFRICAG‑IV‑ERI/1/2019SAT 2VIILib‑12‑ERI/2/2019SAT 2VIILib‑12‑ERI/5/2019SAT 2VIILib‑12‑ERI/6/2019SAT 2VIILib‑12‑ERI/11/2019SAT 2VIILib‑12‑ERI/12/2019SAT 2VIILib‑12‑ERI/13/2019SAT 2VIILib‑12‑ERI/15/2019SAT 2VIILib‑12‑ERI/16/2019SAT 2VIILib‑12‑ERI/17/2019SAT 2VIILib‑12‑ERI/18/2019SAT 2VIILib‑12‑ERI/19/2019SAT 2VIILib‑12‑ERI/20/2019SAT 2VIILib‑12‑ERI/28/2019SAT 2VIILib‑12‑ERI/29/2019SAT 2VIILib‑12‑ERI/2/2015FMDV GDnd‑‑ERI/5/2017FMDV GDnd‑‑ERI/6/2017FMDV GDnd‑‑ERI/1/2018FMDV GDnd‑‑ERI/2/2018FMDV GDnd‑‑ERI/3/2018FMDV GDnd‑‑ERI/5/2018FMDV GDnd‑‑ERI/6/2018FMDV GDnd‑‑ERI/3/2019FMDV GDnd‑‑ERI/4/2019FMDV GDnd‑‑ERI/7/2019FMDV GDnd‑‑ERI/14/2019FMDV GDnd‑‑ERI/21/2019FMDV GDnd‑‑ERI/22/2019FMDV GDnd‑‑ERI/26/2019FMDV GDnd‑‑ERI/30/2019FMDV GDnd‑‑ERI/1/2015NVD ERI/4/2018NVD ERI/8/2019NVD ERI/9/2019NVD ERI/10/2019NVD ERI/23/2019NVD ERI/24/2019NVD ERI/25/2019NVD ERI/27/2019NVD

Notes:

nd, not done*, no virus isolated in cell cultures

Country Information
Samples Tested

Official name:	State of Eritrea
WRLFMD code:	ERI
FMD first recorded:
FMD eradicated:
Subsequent outbreaks:
Serotypes (last rpt):
Current status:	Endemic
Useful websites:

FMDV Serotype	Years (not comprehensive)
Untyped	2005-2009, 2015, 2017-2019
O	1996, 2004, 2011, 2017
A	1997-1998, 2006-2009, 2018
C	-
Asia 1	-
SAT 1	-
SAT 2	2019
SAT 3	-
Notes	prior to 1993 Eritrea was part of Ethiopia

WRLFMD batch no.	Date Received	Virus samples	Type	Topotype	Lineage	Sublineage	WRLFMD Reports
WRLFMD/2004/00032	15/12/2004	ERI/1/2004	O	EA-3	-	-	Detection Genotyping(O)
		ERI/2/2004	O	EA-3	-	-
		ERI/3/2004	O	EA-3	-	-
		ERI/21/2004	O	EA-3	-	-
		ERI/22/2004	O	EA-3	-	-
		ERI/4/2004	NVD
		ERI/5/2004	NVD
		ERI/6/2004	NVD
		ERI/7/2004	NVD
		ERI/8/2004	NVD
		ERI/9/2004	NVD
		ERI/10/2004	NVD
		ERI/11/2004	NVD
		ERI/12/2004	NVD
		ERI/13/2004	NVD
		ERI/14/2004	NVD
		ERI/15/2004	NVD
		ERI/16/2004	NVD
		ERI/17/2004	NVD
		ERI/18/2004	NVD
		ERI/19/2004	NVD
		ERI/20/2004	NVD
		ERI/23/2004	NVD
		ERI/24/2004	NVD
		ERI/25/2004	NVD
		ERI/26/2004	NVD
		ERI/27/2004	NVD
		ERI/28/2004	NVD
		ERI/29/2004	NVD
		ERI/30/2004	NVD
		ERI/31/2004	NVD
WRLFMD/2010/00002	20/01/2010	ERI/1/2006	A	AFRICA	G-IV	-	Detection Genotyping(A) Vaccine
		ERI/5/2006	A	AFRICA	G-IV	-
		ERI/4/2007	A	AFRICA	G-IV	-
		ERI/1/2008	A	AFRICA	G-IV	-
		ERI/5/2008	A	AFRICA	G-IV	-
		ERI/16/2009	A	AFRICA	G-IV	-
		ERI/40/2009	A	AFRICA	G-IV	-
		ERI/1/2005	FMDV GD	nd	‑	‑
		ERI/2/2006	FMDV GD	nd	‑	‑
		ERI/3/2006	FMDV GD	nd	‑	‑
		ERI/4/2006	FMDV GD	nd	‑	‑
		ERI/6/2006	FMDV GD	nd	‑	‑
		ERI/2/2007	FMDV GD	nd	‑	‑
		ERI/3/2007	FMDV GD	nd	‑	‑
		ERI/5/2007	FMDV GD	nd	‑	‑
		ERI/7/2007	FMDV GD	nd	‑	‑
		ERI/8/2007	FMDV GD	nd	‑	‑
		ERI/2/2008	FMDV GD	nd	‑	‑
		ERI/4/2008	FMDV GD	nd	‑	‑
		ERI/1/2009	FMDV GD	nd	‑	‑
		ERI/2/2009	FMDV GD	nd	‑	‑
		ERI/3/2009	FMDV GD	nd	‑	‑
		ERI/4/2009	FMDV GD	nd	‑	‑
		ERI/5/2009	FMDV GD	nd	‑	‑
		ERI/6/2009	FMDV GD	nd	‑	‑
		ERI/7/2009	FMDV GD	nd	‑	‑
		ERI/8/2009	FMDV GD	nd	‑	‑
		ERI/17/2009	FMDV GD	nd	‑	‑
		ERI/29/2009	FMDV GD	nd	‑	‑
		ERI/30/2009	FMDV GD	nd	‑	‑
		ERI/31/2009	FMDV GD	nd	‑	‑
		ERI/32/2009	FMDV GD	nd	‑	‑
		ERI/33/2009	FMDV GD	nd	‑	‑
		ERI/34/2009	FMDV GD	nd	‑	‑
		ERI/66/2009	FMDV GD	nd	‑	‑
		ERI/67/2009	FMDV GD	nd	‑	‑
		ERI/1/2007	NVD
		ERI/6/2007	NVD
		ERI/3/2008	NVD
		ERI/9/2009	NVD
		ERI/10/2009	NVD
		ERI/11/2009	NVD
		ERI/12/2009	NVD
		ERI/13/2009	NVD
		ERI/14/2009	NVD
		ERI/15/2009	NVD
		ERI/18/2009	NVD
		ERI/19/2009	NVD
		ERI/20/2009	NVD
		ERI/21/2009	NVD
		ERI/22/2009	NVD
		ERI/23/2009	NVD
		ERI/24/2009	NVD
		ERI/25/2009	NVD
		ERI/26/2009	NVD
		ERI/27/2009	NVD
		ERI/28/2009	NVD
		ERI/35/2009	NVD
		ERI/36/2009	NVD
		ERI/37/2009	NVD
		ERI/38/2009	NVD
		ERI/39/2009	NVD
		ERI/41/2009	NVD
		ERI/42/2009	NVD
ERI/43/2009	NVD
ERI/44/2009	NVD
ERI/45/2009	NVD
ERI/46/2009	NVD
ERI/47/2009	NVD
ERI/48/2009	NVD
ERI/49/2009	NVD
ERI/50/2009	NVD
ERI/51/2009	NVD
ERI/52/2009	NVD
ERI/53/2009	NVD
ERI/54/2009	NVD
ERI/55/2009	NVD
ERI/56/2009	NVD
ERI/57/2009	NVD
ERI/58/2009	NVD
ERI/59/2009	NVD
ERI/60/2009	NVD
ERI/61/2009	NVD
ERI/62/2009	NVD
ERI/63/2009	NVD
ERI/64/2009	NVD
ERI/65/2009	NVD
ERI/68/2009	NVD
ERI/69/2009	NVD
WRLFMD/2012/00029	01/08/2012	ERI/1/2011	O	EA-3	unnamed	-	Detection Genotyping (O)
		ERI/2/2011	O	EA-3	unnamed	-
		ERI/3/2011	O	EA-3	unnamed	-
		ERI/4/2011	O	EA-3	unnamed	-
		ERI/8/2011	O	EA-3	unnamed	-
		ERI/9/2011*	O	nd	nd	-
		ERI/10/2011	O	EA-3	unnamed	-
		ERI/11/2011	O	EA-3	unnamed	-
		ERI/12/2011	O	EA-3	unnamed	-
		ERI/13/2011	O	EA-3	unnamed	-
		ERI/14/2011	O	EA-3	unnamed	-
		ERI/15/2011	O	EA-3	unnamed	-
		ERI/16/2011	O	EA-3	unnamed	-
		ERI/17/2011	O	EA-3	unnamed	-
		ERI/18/2011	O	EA-3	unnamed	-
		ERI/7/2011	FMDV GD	nd	‑	‑
		ERI/5/2011	NVD
		ERI/6/2011	NVD
WRLFMD/2019/00031	18/12/2019	ERI/1/2017	O	EA‑3	‑	‑	Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine
		ERI/2/2017	O	EA‑3	‑	‑
		ERI/3/2017	O	EA‑3	‑	‑
		ERI/4/2017	O	EA‑3	‑	‑
		ERI/7/2017	O	EA‑3	‑	‑
		ERI/8/2017	O	EA‑3	‑	‑
		ERI/7/2018	A	AFRICA	G‑IV	‑
		ERI/1/2019	SAT 2	VII	Lib‑12	‑
		ERI/2/2019	SAT 2	VII	Lib‑12	‑
		ERI/5/2019	SAT 2	VII	Lib‑12	‑
		ERI/6/2019	SAT 2	VII	Lib‑12	‑
		ERI/11/2019	SAT 2	VII	Lib‑12	‑
		ERI/12/2019	SAT 2	VII	Lib‑12	‑
		ERI/13/2019	SAT 2	VII	Lib‑12	‑
		ERI/15/2019	SAT 2	VII	Lib‑12	‑
		ERI/16/2019	SAT 2	VII	Lib‑12	‑
		ERI/17/2019	SAT 2	VII	Lib‑12	‑
		ERI/18/2019	SAT 2	VII	Lib‑12	‑
		ERI/19/2019	SAT 2	VII	Lib‑12	‑
		ERI/20/2019	SAT 2	VII	Lib‑12	‑
		ERI/28/2019	SAT 2	VII	Lib‑12	‑
		ERI/29/2019	SAT 2	VII	Lib‑12	‑
		ERI/2/2015	FMDV GD	nd	‑	‑
		ERI/5/2017	FMDV GD	nd	‑	‑
		ERI/6/2017	FMDV GD	nd	‑	‑
		ERI/1/2018	FMDV GD	nd	‑	‑
		ERI/2/2018	FMDV GD	nd	‑	‑
		ERI/3/2018	FMDV GD	nd	‑	‑
		ERI/5/2018	FMDV GD	nd	‑	‑
		ERI/6/2018	FMDV GD	nd	‑	‑
		ERI/3/2019	FMDV GD	nd	‑	‑
		ERI/4/2019	FMDV GD	nd	‑	‑
		ERI/7/2019	FMDV GD	nd	‑	‑
		ERI/14/2019	FMDV GD	nd	‑	‑
		ERI/21/2019	FMDV GD	nd	‑	‑
		ERI/22/2019	FMDV GD	nd	‑	‑
		ERI/26/2019	FMDV GD	nd	‑	‑
		ERI/30/2019	FMDV GD	nd	‑	‑
		ERI/1/2015	NVD
		ERI/4/2018	NVD
		ERI/8/2019	NVD
		ERI/9/2019	NVD
		ERI/10/2019	NVD
		ERI/23/2019	NVD
		ERI/24/2019	NVD
		ERI/25/2019	NVD
		ERI/27/2019	NVD

Notes:

nd, not done
*, no virus isolated in cell cultures